FDA Finally Admits The Truth About Their Prenatal Screening Tests

This past Wednesday, Republican Texas Rep. Chip Roy issued a response to the recently reported findings that the Food and Drug Administration (FDA) finally admitted many prenatal screening tests have been issuing entirely false results.

“Yesterday’s admission by the FDA regarding the inherent risks of NIPT screenings marks another step towards protecting life by the most pro-abortion administration in American history,” stated Roy.

“Parents deserve complete information when making complicated medical decisions for their children – especially when these tests can be a matter of life or death,” he continued on.

Roy has stated that his godson was originally recommended for an abortion procedure in the wake of some prenatal screening, stating that just can’t “help but pray for those not as lucky as my godson.”

“His parents chose life,” stated Roy. “The test was wrong. He was born perfectly healthy, and to this day, we are all grateful for the joy he has brought with him into this world.”

These remarks from the congressman crop up just after a Tuesday warning from the FDA of “the risk of false results, inappropriate use and inappropriate interpretation of results with non-invasive prenatal screening (NIPS) tests, also called cell-free DNA tests or non-invasive prenatal tests (NIPT).”

The various prenatal tests, which the FDA has stated are becoming more commonly used as of late, search for genetic anomalies in an unborn baby by running tests on a blood sample taken from the mother.

The FDA put emphasis throughout their press release that these tests give information about the possibility that a child will be born with a “serious health condition,” stating that these are tests are merely for screening, and that more information is needed to make sure a diagnosis on the baby is accurate.

“While genetic non-invasive prenatal screening tests are widely used today, these tests have not been reviewed by the FDA and may be making claims about their performance and use that are not based on sound science,” stated the director of the FDA’s Center for Devices and Radiological Health, Jeff Shuren, in a release.

“Without proper understanding of how these tests should be used, people may make inappropriate health care decisions regarding their pregnancy,” he went on. “We strongly urge patients to discuss the benefits and risks of these tests with a genetic counselor or other health care provider prior to making decisions based on the results of these tests.”

These “inappropriate health care decisions” that he made reference to seem to include abortion, according to a telling report from the New York Times from back in January.

Back in January, Roy urged lawmakers to call upon Janet Woodcock, the Commissioner of the FDA, in order to address the Times report that exposed that competing companies were promising expectant mothers that their tests are “highly” accurate, but failed to publish any sort of data about just how inaccurate their testing is.

 

Share

Leave a Reply

Your email address will not be published. Required fields are marked *